Impact BioMedical Inc.
IBO
$0.78
$0.3268.47%
AMEX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -11.84M | -44.19M | -38.47M | -25.01M | -24.71M |
| Total Depreciation and Amortization | 1.15M | 861.00K | 7.00K | 6.00K | 7.00K |
| Total Amortization of Deferred Charges | 0.00 | 277.00K | 1.12M | 1.12M | 1.11M |
| Total Other Non-Cash Items | 8.20M | 40.43M | 34.51M | 21.44M | 21.34M |
| Change in Net Operating Assets | 600.00K | -353.00K | -534.00K | -603.00K | -608.00K |
| Cash from Operations | -1.89M | -2.98M | -3.36M | -3.05M | -2.85M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 3.00K | 2.00K | 2.00K | 3.00K | 2.00K |
| Cash from Investing | 3.00K | 2.00K | 2.00K | 3.00K | 2.00K |
| Total Debt Issued | 184.00K | 317.00K | 257.00K | 641.00K | 1.12M |
| Total Debt Repaid | -293.00K | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 0.00 | 3.73M | 3.73M | 3.73M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -109.00K | 317.00K | 3.98M | 4.37M | 4.85M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.00M | -2.66M | 622.00K | 1.32M | 2.00M |